FDA Approved: OTREXUP — Supplemental Application (Antares Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for OTREXUP (methotrexate) submitted by Antares Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis
• Plaque Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• OTREXUP (Methotrexate)

Snippet

SUPPL AP for OTREXUP (METHOTREXATE)